BULLISHWHALES
BullishWhales · Analysts · Analyst Profile
BW Score Rank#342 of 347

Jonathan Aschoff

Roth MKM · Equity Research Analyst
ProvisionalRating since 2021No new ratings since Jun 2025

Analyst rating accuracy & track record

Jonathan Aschoff is an equity research analyst at Roth MKM. Bullish Whales has scored 26 of their stock calls across 14 companies. Their picks beat their sector 28% of the time over the next 12 months, and their price targets were reached 19% of the time within a year.

Win % vs sector
28%
PT Hit % (12mo)
19%
Avg sector-excess
−40.8%
Scored calls
26
Tickers
14
Tier
Provisional

Track record

Bullish Whales has scored 26 of Jonathan Aschoff's stock calls across 14 companies, dating back to 2021. Their rated stocks beat their own sector 28% of the time over the next 12 months. On a typical call, a Aschoff pick returned −40.8% more than its sector over the following year.

Of the scored calls, 26 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
BPTHBio Path Holdings Inc
Buy$2.00Jun 2025−113.3%Miss
GTBPGT Biopharma Inc
Buy$11.00Dec 2024−80.2%Miss
ZVRAZevra Therapeutics Inc.
Buy$21.00Sep 2024+27.6%Miss
APVOAptevo Therapeutics Inc
Buy$8.00Sep 2024−89.2%Miss
BRTXBioRestorative Therapies Inc
Buy$18.00Aug 2024+1.7%Miss
NUWENuwellis Inc
Buy$17.00Aug 2024−83.6%Miss
NUWENuwellis Inc
Buy$17.00Jul 2024−82.0%Miss
GOVXGeoVax Labs Inc
Buy$20.00Jul 2024−66.4%Miss
BRTXBioRestorative Therapies Inc
Buy$15.00Jun 2024+7.3%Miss
MBRXMoleculin Biotech Inc
Buy$40.00Apr 2024−83.0%Miss
CLRBCellectar Biosciences Inc
Buy$28.00Mar 2024−91.7%Miss
BPTHBio Path Holdings Inc
Buy$40.00Mar 2024−105.7%Miss
CLRBCellectar Biosciences Inc
Buy$20.00Mar 2024−96.8%Miss
TENXTenax Therapeutics Inc
Buy$30.00Feb 2024+51.8%Miss
TENXTenax Therapeutics Inc
Buy$6.00Nov 2023−104.8%Miss
IMMXImmix Biopharma Inc
Buy$14.00Aug 2023−13.3%Miss
BRTXBioRestorative Therapies Inc
Buy$15.00Aug 2023−59.5%Miss
MBRXMoleculin Biotech Inc
Buy$16.00Apr 2023−69.4%Miss
TENXTenax Therapeutics Inc
Buy$6.00Mar 2023−107.9%Miss
IMMXImmix Biopharma Inc
Buy$14.00Feb 2023+21.7%Miss
REVBRevelation Biosciences Inc
Buy$15.00Feb 2023−107.2%Miss
BRTXBioRestorative Therapies Inc
Buy$15.00Dec 2022−36.6%Miss
HSDTHelius Medical Technologies Inc Class A
Buy$5.00Aug 2022−81.1%Miss
CELZCreative Medical Technology Holdings Inc
Buy$10.00Feb 2022−67.1%Miss
REVBRevelation Biosciences Inc
Buy$12.00Feb 2022−100.3%Miss
APVOAptevo Therapeutics Inc
Buy$50.00May 2021−10.3%Miss
Go to

Jonathan Aschoff: analyst track record FAQ

Is Jonathan Aschoff a good stock analyst?

Yes, by track record. Jonathan Aschoff ranks number 342 of 347 of the analysts Bullish Whales scores, with a BW Score of 0 out of 100. Past results do not guarantee future ones.

What is Jonathan Aschoff's win rate?

Jonathan Aschoff's win rate is 28%. Across 26 scored calls, their rated stocks beat their sector 28% of the time over the next 12 months. On a typical call they returned −40.8% more than the sector.

What stocks and sectors does Jonathan Aschoff cover?

Jonathan Aschoff covers 14 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Jonathan Aschoff's price targets accurate?

Jonathan Aschoff's price targets are reached within 12 months 19% of the time. The base rate across all analysts Bullish Whales tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Bullish Whales scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Jonathan Aschoff's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Bullish Whales score analyst accuracy?

Bullish Whales scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Jonathan Aschoff rank among Wall Street analysts?

Jonathan Aschoff ranks number 342 of 347 by BW Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30